Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.USFDA approves Libtayo for skin cancer treatment
The US Food and Drug Administration (FDA) has approved Libtayo to be used for the treatment of patients having two of the most common skin cancers in the US.
Oncology
-
10 Feb 2021
-
28 Jan 2021
Existing drug offers targeted treatment for aggressive breast cancer
A new study claims palbociclib, an approved breast cancer drug, can treat an aggressive form of the cancer, bringing hope to thousands of afflicted women in the UK.
-
19 Jan 2021
Etana to launch Innovent Biologics’ cancer drug BYVASDA in Indonesia
Chinese pharmaceutical company Innovent Biologics has signed an out-license agreement with Etana Biotechnologies to develop and commercialise cancer drug BYVASDA (Bevacizumab Biosimilar) in Indonesia.